Free Trial

Burning Rock Biotech (BNR) Competitors

Burning Rock Biotech logo
$4.64 +0.04 (+0.87%)
(As of 11/20/2024 ET)

BNR vs. GTH, BDSX, EUDA, QIPT, PIII, XGN, ENZ, MRAI, CCM, and OPGN

Should you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Genetron (GTH), Biodesix (BDSX), EUDA Health (EUDA), Quipt Home Medical (QIPT), P3 Health Partners (PIII), Exagen (XGN), Enzo Biochem (ENZ), Marpai (MRAI), Concord Medical Services (CCM), and OpGen (OPGN).

Burning Rock Biotech vs.

Genetron (NASDAQ:GTH) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment.

10.7% of Genetron shares are owned by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Burning Rock Biotech has lower revenue, but higher earnings than Genetron.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genetron$94.34M1.35-$117.21MN/AN/A
Burning Rock Biotech$75.70M0.63-$92.07M-$4.80-0.97

Burning Rock Biotech received 3 more outperform votes than Genetron when rated by MarketBeat users. However, 33.33% of users gave Genetron an outperform vote while only 31.25% of users gave Burning Rock Biotech an outperform vote.

CompanyUnderperformOutperform
GenetronOutperform Votes
2
33.33%
Underperform Votes
4
66.67%
Burning Rock BiotechOutperform Votes
5
31.25%
Underperform Votes
11
68.75%

In the previous week, Genetron's average media sentiment score of 0.00 equaled Burning Rock Biotech'saverage media sentiment score.

Company Overall Sentiment
Genetron Neutral
Burning Rock Biotech Neutral

Genetron has a net margin of 0.00% compared to Burning Rock Biotech's net margin of -111.25%. Genetron's return on equity of 0.00% beat Burning Rock Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
GenetronN/A N/A N/A
Burning Rock Biotech -111.25%-74.96%-53.82%

Genetron has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.14, meaning that its stock price is 86% less volatile than the S&P 500.

Summary

Genetron beats Burning Rock Biotech on 7 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BNR vs. The Competition

MetricBurning Rock BiotechMedical laboratories IndustryBusiness SectorNASDAQ Exchange
Market Cap$47.12M$3.06B$6.61B$8.89B
Dividend YieldN/A11.18%2.93%4.07%
P/E Ratio-0.978.5133.7712.93
Price / Sales0.63215.99175.7688.33
Price / CashN/A406.7825.2436.25
Price / Book0.443.314.846.25
Net Income-$92.07M-$32.86M$123.37M$225.93M
7 Day Performance25.41%0.56%0.13%-1.32%
1 Month Performance52.63%-0.22%8.35%0.60%
1 Year Performance-48.45%26.01%29.92%26.23%

Burning Rock Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BNR
Burning Rock Biotech
N/A$4.64
+0.9%
N/A-48.5%$47.12M$75.70M-0.971,390
GTH
Genetron
N/A$4.03
+0.2%
N/A+7.8%$127.43M$94.34M0.00993High Trading Volume
BDSX
Biodesix
2.6823 of 5 stars
$1.19
-4.0%
$3.06
+157.1%
-16.2%$180.38M$49.09M0.00220Negative News
High Trading Volume
EUDA
EUDA Health
0.1736 of 5 stars
$4.38
+0.9%
N/A+284.2%$106.88M$3.71M0.002
QIPT
Quipt Home Medical
3.2122 of 5 stars
$2.42
-1.2%
$6.25
+158.3%
-51.2%$105.57M$221.74M0.001,200News Coverage
PIII
P3 Health Partners
3.2506 of 5 stars
$0.20
-4.7%
$2.38
+1,065.4%
-82.9%$75.44M$1.27B0.00500Analyst Forecast
Analyst Revision
High Trading Volume
XGN
Exagen
4.7894 of 5 stars
$4.20
+19.0%
$7.00
+66.7%
+169.2%$62.26M$52.55M0.00220Analyst Revision
Gap Up
High Trading Volume
ENZ
Enzo Biochem
0.5158 of 5 stars
$0.99
-2.0%
N/A-22.3%$52.77M$31.91M0.00520
MRAI
Marpai
2.0113 of 5 stars
$1.64
+13.1%
$6.00
+265.9%
+80.2%$19.92M$37.15M-0.62150
CCM
Concord Medical Services
0.3558 of 5 stars
$4.35
-3.3%
N/A-58.6%$19.54M$75.69M0.00970Gap Up
OPGN
OpGen
N/A$1.99
+1.5%
N/A-55.8%$16.40M$3.42M0.00100News Coverage

Related Companies and Tools


This page (NASDAQ:BNR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners